The FTC has claimed that the merger violates federal anti-trust regulations. If an injunction is granted, HIT and other projects would be suspended, and St. Luke’s would have to reassume the liabilities ProMedica had pledged to cover, according to the report.
An administrative trial has been scheduled in the case for May 31 to determine if the merger would need to be dissolved permanently. This decision, however, could be appealed.
Read the Toledo Blade report on the St. Luke’s, ProMedica merger.
Read more coverage on the St. Luke’s, ProMedica merger:
– FTC Drops Request for Restraining Order on ProMedica, St. Luke’s Merger
– Ohio System Says FTC Challenge of Merger ‘Inconsistent’ With Call for Integration
– FTC Files Request in Ohio District Court for Information on St. Luke’s, ProMedica Merger
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
